AdvisorShares Psychedelics ETF Rating $13.65 -0.37 (-2.64%) Closing price 02/21/2025 04:10 PM EasternExtended Trading$13.74 +0.08 (+0.62%) As of 02/21/2025 04:11 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ratings Stock AnalysisChartHoldingsOwnershipRatings AdvisorShares Psychedelics ETF Aggregate Rating and Price Target (2025)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.PSIL Aggregate RatingModerate Buy 2.95Holdings in PSIL have an aggregate rating of Moderate Buy based on 110 analyst ratings issued in the past year covering 12 companies (70.5% of the portfolio).PSIL Aggregate Price Target$13.65High Prediction$13.65Average Prediction$13.65Low Prediction$13.65Holdings in PSIL have an aggregate price target of $13.65 and a range of $13.65 to $13.65 covering 12 companies (70.5% of the portfolio).PSIL Consensus Ratings of HoldingsStrong Buy1 Strong Buy rating(s)Buy5 Buy rating(s)Moderate Buy4 Moderate Buy rating(s)Hold2 Hold rating(s)Reduce0 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by AdvisorShares Psychedelics ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 12 PSIL Holdings Export to ExcelWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings9.38%MNMDMind Medicine (MindMed)$7.63-6.7%2.3077 of 5 stars3.23$26.33 245.1%13Gap Up7.80%ATAIAtai Life Sciences$1.99-2.5%3.114 of 5 stars3.00$9.00 352.3%4Insider TradeNews Coverage7.49%STIMNeuronetics$4.13-14.0%1.848 of 5 stars2.75$4.67 13.0%46.94%NRXPNRx Pharmaceuticals$2.28-6.9%2.6644 of 5 stars3.25$31.67 1,288.9%46.61%ALKSAlkermes$35.33-0.5%3.6896 of 5 stars2.82$38.36 8.6%116.32%GHRSGH Research$12.51-10.7%2.5189 of 5 stars3.00$30.25 141.9%45.53%SAGESage Therapeutics$7.31+2.2%4.6184 of 5 stars2.00$9.65 32.0%205.41%CMPSCOMPASS Pathways$4.21-7.3%1.7 of 5 stars3.00$30.60 626.8%65.04%ITCIIntra-Cellular Therapies$128.60+0.0%3.916 of 5 stars2.53$103.62 -19.4%15Earnings ReportAnalyst ForecastNews Coverage4.79%VTGNVistagen Therapeutics$2.93+2.1%0.7535 of 5 stars4.0014.37%NBIXNeurocrine Biosciences$120.69+3.9%4.9825 of 5 stars2.83$166.90 38.3%23Analyst DowngradeBuyback AnnouncementAnalyst RevisionGap Up0.84%RLMDRelmada Therapeutics$0.30-6.1%4.3231 of 5 stars2.00$4.25 1,340.7%5Gap Down This page (NYSEARCA:PSIL) was last updated on 2/22/2025 by MarketBeat.com Staff From Our PartnersWhat is this southern state hiding?The financial press had a field day this week after President Donald Trump and Department of Government Effici...Stansberry Research | SponsoredWhy Buffett and 100 members of Congress are Piling into this One InvestmentThis isn't just another investment. It might be the last retirement stock you'll ever need. But this win...Behind the Markets | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredBuy NVDA Now? After weeks of volatility, did President Trump just turn Nvidia (NVDA) into a raging BUY? The beloved chip...Chaikin Analytics | SponsoredThis Crypto Is Set to Explode in FebruaryIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredElon’s “New Gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | SponsoredMarket down? Do this now.During Trump's first term, his tariffs sent gold prices soaring. Investors who acted early made a fortune. Now...Colonial Metals | SponsoredElon Takes Aim at Social SecurityElon Musk just dropped another bombshell... He revealed his DOGE organization has been taking aim at Social...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding AdvisorShares Psychedelics ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share AdvisorShares Psychedelics ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.